Which patient, what assessment and by whom? Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015
Managing patient pathways to achieve lung cancer waiting time targets: Mixed method study Source: Annual Congress 2011 - How to improve lung cancer care Year: 2011
Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014
Does a “first sample into the pot” methodology improve the yield to enable molecular testing on samples obtained by EBUS? Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
A patient evaluation of performing COPD research in primary care. Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
Modeling of final results in treatment and diagnostic process as effective control form of work quality in pulmonologic hospital Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005
Which method is effective in patient with asthma to guide the treatment? (2 year follow-up study) Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours? Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables. Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019
What comes next? The SPIKES protocol and the subject of prognosis Source: International Congress 2015 – Deliver bad news Year: 2015
A retrospective analysis of patient presentation to primary and secondary care prior to subsequent late stage lung cancer diagnosis Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the investigations requested? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Is information given to the patient prior to the bronchoscopic procedure adequate and understandable? Source: Eur Respir J 2003; 22: Suppl. 45, 512s Year: 2003
COPD detected with screening: impact on patient management and prognosis Source: Eur Respir J 2014; 44: 1571-1578 Year: 2014
Feasibility of typical asthma study patients related to a larger real life patient population Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002